Harvard, MIT, Berkeley are still fighting over genome editing patents. Now another rulingThomas Claburnon March 2, 2022 at 01:13 The Register


Who says organic chemistry doesn’t have its drama?

The US Patent Office’s appeal board on Monday sided with Harvard University and MIT by upholding a set of the group’s patents covering CRISPR-Cas9 genome editing in plants and animals.…

Leave a Comment